# Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

> **NCT01491113** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 30 (actual)

## Conditions studied

- Healthy Subjects
- Renal Impairments

## Interventions

- **DRUG:** Levetiracetam 250 mg
- **DRUG:** Levetiracetam 500 mg

## Key facts

- **NCT ID:** NCT01491113
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01491113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01491113, "Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01491113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*